Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107641621B reveals a dual-enzyme method for Icaritin. Achieve 98.3% conversion with thermostable glycosidases for cost-effective manufacturing.
Novel silica-supported catalyst enables efficient Fluoxastrobin production. Reduces waste, improves yield, ensures supply chain stability for agrochemical manufacturers.
Novel Lewis acid catalyzed route offers high purity N-methylpiperazine with significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel visible-light synthesis of 1-iodo-3-perfluoroalkyl olefins. Cost-effective, scalable manufacturing for pharmaceutical and agrochemical intermediates with high Z-selectivity.
Patent CN111393440A details a green acidic ionic liquid catalytic route for high-purity naphthyridine derivatives, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN106947792A reveals enzymatic route for Lifitegrast intermediate. Delivers high purity and cost reduction in API intermediate manufacturing for global supply chains.
Patent CN104003991A details a novel asymmetric synthesis for Balasubramide derivatives. Achieve high enantioselectivity and scalable production for neuroprotective drug development.
Patent CN119977744B reveals a novel Pd-catalyzed telomerization method. Achieve high selectivity and reduced catalyst costs for scalable production.
Advanced manufacturing process for aminomethanephosphonic acid via urea derivative phosphonation. Offers cost reduction and scalable supply chain solutions for glyphosate precursors.
Patent CN113979975A details a metal-free chiral phosphoric acid catalyzed kinetic resolution for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Novel heteropoly acid catalyst method for 1-N-ethyl gentamicin C1a synthesis. Significantly improves yield and purity. Reliable pharmaceutical intermediates supplier for scale-up.
Patent CN106674288B reveals a one-pot synthesis for oxapropylene [Fe-Fe] hydrogenase models. Discover cost-effective manufacturing and scalable supply chain solutions for advanced catalysts.
Patent CN115927500A details a novel enzymatic route for scopoletin using ferulic acid. Discover cost-effective, scalable biocatalysis for pharmaceutical supply chains.
Novel ionic liquid method for acridone derivatives ensures high yield and reduced waste. Ideal for pharmaceutical intermediate supply chains seeking cost efficiency and scalability.
Patent CN102911084A details a green synthesis of tert-butyl carbazate using magnetic hydrotalcite catalysts. Achieve high purity and reduced costs in API manufacturing.
Patent CN102911084A details a green synthesis of tert-butyl carbazate using magnetic hydrotalcite catalysts. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturers.
Patent CN102816116B details a green synthesis of 6-hydroxy-2(1H)-quinolinone using Gemini surfactants, offering cost reduction and scalable manufacturing for cardiovascular intermediates.
Patent CN101671376B details a novel 4-step synthesis of alkannin acetyl glucose. Discover cost-effective manufacturing and high-purity anti-tumor intermediates.
Patent CN107904268A reveals enzymatic route for D-cyclic amino acids. Offers high purity, reduced waste, and scalable manufacturing for pharmaceutical intermediates.
Novel lipase Ndbn enables green aromatic amide synthesis with enhanced stability. Offers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing.